FDA found B. cepacia contamination and CGMP failures at Spartan Chemical’s hand sanitizer plant, plus unapproved COVID-19 claims.
What happened
FDA inspected Spartan Chemical’s Maumee, Ohio drug manufacturing facility from March 1 to 26, 2021. FDA laboratory testing of Lite’n Foamy Lemon Blossom Hand Sanitizer lot 538756 found Burkholderia cepacia complex and high total microbial and yeast/mold counts. FDA also reviewed the company’s website on October 8, 2021 and labeling, and found COVID-19 claims and statements that products were FDA registered and approved.
What FDA found
Spartan used water from a system that lacked performance qualification and routine monitoring to make aqueous drug products.
21 CFR 211.100(a)Spartan’s investigations of failing microbial results, including B. cepacia contamination, did not find root cause, assess distributed batches, or require effective corrective actions.
21 CFR 211.192Spartan’s quality unit did not adequately oversee manufacturing, change control, product reviews, training, or microbial testing such as B. cepacia suitability and antimicrobial effectiveness testing.
21 CFR 211.22FDA found B. cepacia complex and high total microbial and yeast/mold counts in Lite’n Foamy Lemon Blossom Hand Sanitizer lot 538756, showing insanitary manufacturing conditions.
FD&C Act section 501(a)(2)(A), 21 U.S.C. 351(a)(2)(A)The foamyiQ and Lite’n Foamy antiseptic products were marketed with COVID-19 claims without an approved new drug application.
FD&C Act section 505(a), 21 U.S.C. 355(a)The products’ labeling falsely stated they were FDA registered and approved.
FD&C Act sections 502(a) and (ee), 21 U.S.C. 352(a) and (ee)
What FDA wants
FDA asks Spartan to provide comprehensive remediation plans and independent assessments for its water system, investigations and CAPA, quality unit, change control, cleaning validation, and antimicrobial effectiveness testing. The provided letter does not state a response deadline.
Who should pay attention
- brands and distributors that sell Spartan hand sanitizers
- contract manufacturers of water-based OTC antiseptics
- quality units responsible for water systems and microbial investigations
This is a summary. Read the original letter on fda.gov.